IRVINE, Calif.--(BUSINESS WIRE)--Oct. 3, 2005--Allergan, Inc. (NYSE:AGN) announced today that it has entered into a long-term agreement with GlaxoSmithKline (NYSE:GSK) to develop and promote ...

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced yesterday that it has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.5 mL For Subcutaneous Use, a ...

HYDERABAD, India — Dr. Reddy's Labs announced that it has launched Sumatriptan Injection USP, Autoinjector System 6-mg/0.5-mL, a generic version of Imitrex STATdose Pen (sumatriptan succinate) ...

US group Allergan has entered into a long-term agreement with UK drug giant GlaxoSmithKline to develop and market its Botox (botulinum toxin type A) in Japan and China, and to co-promote GSK’s ...

Sumatriptan (as succinate) 4mg/0.5mL, 6mg/0.5mL; for SC inj. Imitrex Injection is supplied as a clear, colorless to pale yellow, sterile, nonpyrogenic solution as either prefilled syringe and/or ...

Allergansaid Monday that it has licensed certain foreign rights for its Botox wrinkle treatment to GlaxoSmithKline, adding that it will significantly restructure its Japanese operations to accommodate ...

The injection is an auto-injector system for subcutaneous use. It is a therapeutic equivalent generic version of Imitrex Statdose Pen (sumatriptan succinate) and was launched in the US market today ...

Dr. Reddy’s Laboratories announced the launch of Sumatriptan Injection Autoinjector System for Subcutaneous Use, the generic version of GlaxoSmithKline‘s Imitrex STATdose Pen. Sumatriptan is a ...

RESEARCH TRIANGLE PARK, N.C., Feb. 2 (UPI) -- GlaxoSmithKline said Thursday the Food and Drug Administration approved a new formulation of its migraine treatment Imitrex injection. The approval is for ...

Dr Reddy’s Laboratories announced on today that it has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.5 mL, for subcutaneous use in the US market on February 25. It is a therapeutic ...